Atara Biotherapeutics Inc (ATRA)
13.44
-0.94
(-6.54%)
USD |
NASDAQ |
Nov 14, 12:41
Atara Biotherapeutics Gross Profit Margin (Quarterly): 83.84% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 83.84% |
| March 31, 2024 | 92.74% |
| December 31, 2023 | 25.68% |
| Date | Value |
|---|---|
| September 30, 2023 | -22.31% |
| June 30, 2023 | -202.5% |
| March 31, 2023 | 82.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-202.5%
Minimum
Jun 2023
92.74%
Maximum
Mar 2024
9.97%
Average
54.03%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -102.5% |
| Profit Margin (Quarterly) | -66.51% |
| Operating Margin (Quarterly) | -63.66% |
| Return on Net Operating Assets | -211.3% |